Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
ReachMD CME
Claim This Podcastby ReachMD
4.2(4 reviews)
1,707 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
34
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality33
Social0
YouTube0
Engagement85
Podcast Overview
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
Language
🇺🇲
Publishing Since
7/11/2019
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
34
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality33
Social0
YouTube0
Engagement85
5
Excellent Areas
1
Good Performance
13
Growth Opportunities
excellent
Publishing Consistency
Every 2 days
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Episode Length
0 seconds
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for ReachMD CME
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 23, 2026
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
CME credits: 0.25<br> Valid until: 23-06-2027<br> Claim your CME credit at <a href="https://reachmd.com/programs/cme/translating-evidence-into-action-nonsteroidal-mras-in-patients-with-hf/49259/">https://reachmd.com/programs/cme/translating-evidence-into-action-nonsteroidal-mras-in-patients-with-hf/49259/</a><br> <p>In this panel discussion from the ESC Heart Failure Congress 2026, Drs. Muthu Vaduganathan, Michael Böhm, and Koichiro Kinugawa discuss the role of nonsteroidal MRAs in patients with HFmrEF and HFpEF. Using a clinical case, the faculty review evolving recommendations supporting finerenone as part of guideline-directed medical therapy, along with evidence from FINEARTS-HF and related analyses. The discussion highlights considerations for early initiation, use in combination with SGLT2 inhibitors, patient selection, dosing and monitoring, and management of potassium and renal function changes in clinical practice.</p>=
June 16, 2026
Unblocking Clinical Inertia: The CMI Era in oHCM Care
CME credits: 0.75<br> Valid until: 16-06-2027<br> Claim your CME credit at <a href="https://reachmd.com/programs/cme/unblocking-clinical-inertia-the-cmi-era-in-ohcm-care/56382/">https://reachmd.com/programs/cme/unblocking-clinical-inertia-the-cmi-era-in-ohcm-care/56382/</a><br> <p>Did you miss our symposium at ESC HF 2026? It’s not too late! This CME-accredited broadcast replay focuses on improving the diagnosis and management of obstructive hypertrophic cardiomyopathy (oHCM). Learn how to distinguish oHCM from heart failure and how cardiac myosin inhibitors can optimize patient outcomes. Join us and gain valuable tips on applying these insights in practice.<br/><br/>For more information please visit the <a href="https://www.escardio.org/events/congresses/heart-failure/?_gl=1*1nqzpgz*_up*MQ..*_gs*MQ..&gclid=Cj0KCQjwmunNBhDbARIsAOndKpl7sjZfVvOVHUWyv4ueorZspZCyuuIHkPsgzNUCRWVEdfapnpn3U-waAnlQEALw_wcB&gbraid=0AAAAAD4VFqaDKIwtyhiSlbGXqUH5bRzzv">Heart Failure Congress 2026 website</a>.</p>=
May 8, 2026
FXIa Remix! Keeping the Flow Without Missing a Beat
CME credits: 0.50<br> Valid until: 01-05-2027<br> Claim your CME credit at <a href="https://reachmd.com/programs/cme/fxia-remix-keeping-the-flow-without-missing-a-beat/54142/">https://reachmd.com/programs/cme/fxia-remix-keeping-the-flow-without-missing-a-beat/54142/</a><br> <p>Can an antithrombotic meaningfully reduce the risk of recurrent ischemic stroke without increasing major bleeding? Drs. Mike Sharma, Ashkan Shoamanesh, and Brian Mac Grory explore the science behind factor XIa inhibition and its potential to decouple thrombosis from hemostasis. The panel reviews pivotal OCEANIC-STROKE results presented at ISC 2026, highlighting a 26% relative risk reduction in ischemic stroke without an observed increase in ISTH major bleeding. They examine outcomes across stroke subtypes and place these results in context with other agents in development, such as milvexian and abelacimab. This conversation considers whether factor XI inhibition may alter long-standing assumptions about the tradeoff between efficacy and safety in secondary stroke prevention.</p>=
1,707 total episodes available
Deep-dive analytics for ReachMD CME
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is ReachMD CME?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.